US awards Moderna $176 MN bird flu vaccine contract
The company's shares boosted 2% in early Tuesday trade after announcing the deal, sparked by fears based on three human cases of H5N1 virus infections since March and an outbreak among cows.
Scientists are apparently concerned the virus could mutate and spark another pandemic.
While Big Pharma is concerned that a lack of public pandemic panic is hurting their profit margins?
Send us a news tip, Advert/ Promotion enquiries, General enquiries, Complain about a story, Submit an opinion, Submit a photo, audio or video etc. Call/ WhatsApp +2348065195638
Post a Comment
Let know your opinion on this story